1991
DOI: 10.1007/bf00966597
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists

Abstract: The effect of centrally and peripherally administered dopamine D1 and D2 specific compounds on core body temperature in mice was investigated. Quinpirole (LY-17155), a D2 agonist, induced a dose-dependent fall in body temperature (2.4-11.6%; p less than 0.003) when injected intraperitoneally (ip, 0.3-3.0 mg/kg) and intracerebroventricularly (icv, 0.1 mg/kg). This quinpirole-induced (1.0 mg/kg, ip) hypothermia was reversed by the central and peripheral administration of the D2 antagonists S-(-)-sulpiride (3.0-3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(14 citation statements)
references
References 24 publications
0
14
0
Order By: Relevance
“…Brain-penetrant dopamine agonists cause hypothermia via both D1-like and D2-like receptors (Carboni et al, 1986; Nunes et al, 1991), referred to hereafter as D1 and D2. Individually, a D1 antagonist (SCH23390, 2 mg/kg ip) or a D2 antagonist (sulpiride, 30 mg/kg ip) partially inhibited MTII hypothermia, while the combined inhibitors completely blocked MTII hypothermia (Figure 6A,B).…”
Section: Resultsmentioning
confidence: 99%
“…Brain-penetrant dopamine agonists cause hypothermia via both D1-like and D2-like receptors (Carboni et al, 1986; Nunes et al, 1991), referred to hereafter as D1 and D2. Individually, a D1 antagonist (SCH23390, 2 mg/kg ip) or a D2 antagonist (sulpiride, 30 mg/kg ip) partially inhibited MTII hypothermia, while the combined inhibitors completely blocked MTII hypothermia (Figure 6A,B).…”
Section: Resultsmentioning
confidence: 99%
“…Dopamine has a well documented role in heat loss mechanisms in the preoptic anterior hypothalamus area (Hasegawa et al 2000), which is the main thermoregulatory centre in the brain (Boulant 2000). Also, drugs which augment dopamine metabolism in this area have a vasodilatory effect and cause a fall in core and brain temperature, whereas dopamine antagonists have the opposite effect (Nunes et al 1991). If the supplementary tyrosine in the present study maintained dopamine metabolism in the hypothalamus thus reducing the rate of Tcore increase, then this was not reflected by a lower body heat content and higher sweat rates and body mass losses in TYR.…”
Section: Discussionmentioning
confidence: 99%
“…In rats or mice SCH had no effect on body temperature when administered subcutaneously or intracerboventricularly at various doses up to 0.5 mg/kg ( [7,9,33,37,38]. Faunt and Crocker [13] evaluated the effects of various doses of SCH on body temperature in male Sprague Dawley rats over a period of three hours.…”
Section: Effects Of Sch On Body Temperaturementioning
confidence: 99%